Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
$AMGN, a biopharma company, hinted at positive results for its weight loss drug MariTide. Analysts are assessing its potential against competitors like $NVO and $LLY. Cathie Wood's Ark Invest bought $3.54M worth of $AMGN shares. Traders shorted $AMGN and bought $LLY and $VKTX.
the new $PFE BD/strategy fella .. <3 him already https://t.co/NKrpM4JNFg
Very interesting that $AMGN also tried N-terminal GLP-1 fusion between GIPR mAb and GLP-1. But looks interfered with GIPR binding (see high IC50) and also had short half-lives. https://t.co/U22c3kwWuf https://t.co/zFDHh6UB1Z
$LLY weaker hands flushed last week on silly $AMGN move It worked both ways by buying $LLY dips and shorting $AMGN big valuation spike https://t.co/V4SQQdF6Wk